Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05031494
What this trial is testing

Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers

Who this might be right for
MelanomaPancreatic Ductal Adenocarcinoma
Eucure (Beijing) Biopharma Co., Ltd 40
Early research (Phase 1)Looking for participantsNCT07237594
What this trial is testing

IL-17 Blockade to Decrease irAEs (REPLAY)

Who this might be right for
Metastatic Melanoma
Duke University 4
Early research (Phase 1)Study completedNCT04423029
What this trial is testing

DF6002 Alone and in Combination With Nivolumab

Who this might be right for
Solid Tumors
Dragonfly Therapeutics 170
Very early researchEnded earlyNCT02591654
What this trial is testing

MRI and PET to Assess Pembrolizumab Response

Who this might be right for
Malignant Melanoma, Metastatic
Columbia University 6
Testing effectiveness (Phase 2)Study completedNCT02178722
What this trial is testing

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Who this might be right for
Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Endometrial CancerHead and Neck Cancer+11 more
Incyte Corporation 444
Early research (Phase 1)Study completedNCT00104845
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center 19
Large-scale testing (Phase 3)Study completedNCT00039000
What this trial is testing

Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma

Who this might be right for
Malignant Melanoma
Agenus Inc. 350
Testing effectiveness (Phase 2)Study completedNCT03973151
What this trial is testing

Study of HL-085 in NRAS Mutant Advanced Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 42
Testing effectiveness (Phase 2)Study completedNCT00033228
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Mannkind Corporation 19
Not applicableNo Longer AvailableNCT00495066
What this trial is testing

Compassionate Use Trial for Unresectable Melanoma With Ipilimumab

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT02576431
What this trial is testing

Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 215
Testing effectiveness (Phase 2)Ended earlyNCT01701037
What this trial is testing

Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIB Melanoma (Locally Advanced)Stage IIC Melanoma (Locally Advanced)+4 more
Vanderbilt-Ingram Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03235245
What this trial is testing

Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With Encorafenib and Binimetinib

Who this might be right for
Unresectable Stage III MelanomaStage IV Melanoma
European Organisation for Research and Treatment of Cancer - EORTC 271
Testing effectiveness (Phase 2)Study completedNCT00020475
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Who this might be right for
Extraocular Extension MelanomaRecurrent Intraocular Melanoma
National Cancer Institute (NCI)
Not applicableUnknownNCT04169867
What this trial is testing

Polish Microbiome Map

Who this might be right for
MelanomaHealthy VolunteersMicrobiome+2 more
Ardigen 1,160
Testing effectiveness (Phase 2)Ended earlyNCT00961844
What this trial is testing

Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant Melanoma

Who this might be right for
Metastatic Malignant Melanoma
Steinar Aamdal 15
Testing effectiveness (Phase 2)WithdrawnNCT03297463
What this trial is testing

Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma

Who this might be right for
Metastatic MelanomaPulmonary MetastasesHepatic Metastases+1 more
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Study completedNCT01603212
What this trial is testing

Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT04068181
What this trial is testing

Talimogene Laherparepvec With Pembrolizumab in Melanoma Following Progression on Prior Anti-PD-1 Based Therapy (MASTERKEY-115) (Mk-3475-A07/KEYNOTE-A07).

Who this might be right for
Melanoma
Amgen 72
Early research (Phase 1)UnknownNCT05451407
What this trial is testing

Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 50
Next Page